Company / Operating Cash Flow per Share
Century Therapeutics, Inc. Operating Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.28
FY2025
5-year range
-$1.52 / $0.26
FY2022-FY2025
Trend
+12.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.26 to $-1.28 over the past 2 years.
Based on SEC 10-K filings.
-1.28 in FY2025.
Declined from $0.26 to $-1.28 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 12.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.28 | +12.4% |
| FY2024 | -$1.46 | -673.2% |
| FY2023 | $0.26 | +116.8% |
| FY2022 | -$1.52 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026